MMP2 and pancreatic neoplasm: With the development of protein molecular technology and proteomics, several serum protein molecules characteristic of early pancreatic cancer have been identified, including matrix metalloproteinase MMP-2, MMP-9, [24] and serum galactoagglutinin-3 [25].